Trial: 201808163

A Phase III Randomized, Double-Blind Trial to Evaluate the Efficacy of Uproleselan Administered with Chemotherapy versus Chemotherapy Alone in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Phase

III

Principal Investigator

Uy, Geoffrey

Disease Site

Acute Myeloid Leukemia (AML); Myeloid and Monocytic Leukemia

Learn more about this study at: clinicaltrials.gov